AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
ASPX was delisted on the 4th of May, 2015.
61 hedge funds and large institutions have $198M invested in AUSPEX PHARMACEUTICALS INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 8 closing their positions.
188% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 8
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
30% more funds holding
Funds holding: 47 → 61 (+14)
27% less capital invested
Capital invested by funds: $271M → $198M (-$73M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$5.23M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.15M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.33M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$2.33M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.39M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$5.18M |
| 2 |
Bank of New York Mellon
New York
|
-$3.38M |
| 3 |
AWMDMG
Austin W. Marxe & David M. Greenhouse
New York
|
-$2.45M |
| 4 |
KCM
Kingdon Capital Management
New York
|
-$2.14M |
| 5 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$1.8M |
ASPX Hedge Fund Activity: Q2 2014 in Review
61 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) for Q2 2014, worth a combined $198M — down 27% from $271M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new ASPX positions and 8 closed out — a net gain of 15 holders — while 20 added to existing stakes and 14 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $5.23M. The largest seller was Millennium Management, cutting an estimated $5.18M.
- 61 institutional investors held AUSPEX PHARMACEUTICALS INC COM STK (DE) (ASPX) as of Q2 2014, up from 47 in Q1 2014.
- Funds reported $198M of AUSPEX PHARMACEUTICALS INC COM STK (DE) stock for Q2 2014, down 27% quarter-over-quarter.
- 23 funds opened new AUSPEX PHARMACEUTICALS INC COM STK (DE) positions in Q2 2014 and 8 closed out, a net change of +15 holders.
- The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) buyer in Q2 2014 was JP Morgan Chase, an estimated $5.23M added.
- The largest AUSPEX PHARMACEUTICALS INC COM STK (DE) seller in Q2 2014 was Millennium Management, an estimated $5.18M sold.
Based on aggregated 13F filings for Q2 2014.